Abstract:Background & Aims: Hepatitis B virus (HBV) has developed strategies to evade immune responses. However, the mechanisms involved remain unclear. The NLRP3 inflammasome plays crucial roles in antiviral host defense and its downstream factor IL-1 beta has been shown to inhibit HBV infection in vivo. This study aims to assess whether HBV can affect the NLRP3 inflammasome signaling pathways and shed light on the underlying mechanisms HBV utilizes to evade host innate immune responses.Methods: HBV inhibition of the lipopolysaccharide (LPS)-induced NLRP3 inflammasome activation was evaluated by Western blot, quantitative RT-PCR, flow cytometry and immunofluorescence.Results: Kupffer cells expressed significantly more NLRP3 and IL-1 beta after LPS stimulation; whereas, chronic HBV infection suppressed LPS-induced NLRP3 and pro-IL-1 beta expression as well as IL-1 beta maturation. This inhibitory activity is mediated by HBeAg, and is involved in the inhibition of NF-kappa B signal pathway and reactive oxygen species (ROS) production. The inhibitory effect of HBeAg was confirmed in patients with chronic hepatitis B (CHB) and hepatocellular carcinoma by comparing the levels of IL-1 beta and NLRP3-related proteins in para-carcinoma tissues from HBeAg-positive or negative patients. Moreover, chronic HBV infection increases the susceptibility of mice to S. typhimurium infection, possibly via inhibiting the NLRP3 inflammasome activation and IL-1b production.Conclusions: HBeAg inhibits LPS-induced NLRP3 inflammasome activation and IL-1 beta production via suppressing NF-kappa B pathway and ROS production. This finding provides a novel mechanism for HBV-mediated suppression of innate immune responses, and identifies new therapeutic targets for chronic HBV infection and related diseases.Lay summary: HBeAg suppresses LPS-induced NLRP3 inflammasome activation and IL-1 beta production in two ways, one is to repress NLRP3 and pro-IL-1 beta expression via inhibiting NF-kappa B phosphorylation, and the other is to repress caspase-1 activation and IL-1 beta maturation via inhibiting ROS production. This effect contributes to the HBV persistence and immune tolerance. (C) 2016 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.

Hepatitis B Virus Middle Protein Enhances Il-6 Production Via P38 Mapk/Nf-Kappa B Pathways In An Er Stress-Dependent Manner

Hepatitis B Virus Middle Protein Enhances IL-6 Production via p38 MAPK/NF-κB Pathways in an ER Stress-Dependent Manner

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

Hepatitis B Virus Core Antigen Stimulates IL-6 Expression via p38, ERK and NF-κB Pathways in Hepatocytes.

Hepatitis B Virus X Protein Stimulates IL-6 Expression in Hepatocytes Via a MyD88-dependent Pathway.

HBV Inhibits LPS-induced NLRP3 Inflammasome Activation and IL-1β Production Via Suppressing the NF-κB Pathway and ROS Production.

Apolipoprotein H Drives Hepatitis B Surface Antigen Retention and Endoplasmic Reticulum Stress During Hepatitis B Virus Infection.

Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response.

Hepatitis B Virus X Protein Binding To Hepsin Promotes C3 Production By Inducing Il-6 Secretion From Hepatocytes

Endoplasmic reticulum stress promotes HBV production by enhancing use of the autophagosome/multivesicular body axis

ER stress promotes HBV production by enhancing utilization of the autophagosome- multivesicular body axis

HBV X Protein Induces Overexpression of HERV-W Env Through NF-κB in HepG2 Cells

Effects of Hepatitis B virus X protein on the expression of interferon-induced MxA protein

Hepatitis B Virus X Protein Promotes Liver Cell Proliferation Via a Positive Cascade Loop Involving Arachidonic Acid Metabolism and P-Erk1/2

The Hepatitis B Virus X Protein Disrupts Innate Immunity by Downregulating Mitochondrial Antiviral Signaling Protein

Role of Small Envelope Protein in Sustaining the Intracellular and Extracellular Levels of Hepatitis B Virus Large and Middle Envelope Proteins

Upregulation of IL-23 Expression in Patients with Chronic Hepatitis B is Mediated by the HBx/ERK/NF-κB Pathway.

Elevated IL-6 Receptor Expression on CD4+ T Cells Contributes to the Increased Th17 Responses in Patients with Chronic Hepatitis B

Hepatitis B Virus Core Protein Sensitizes Hepatocytes to Tumor Necrosis Factor-Induced Apoptosis by Suppression of the Phosphorylation of Mitogen-Activated Protein Kinase Kinase 7

Hepatitis B Virus Induces Microtubule Stabilization to Promote Productive Infection through Upregulating Microtubule-associated Protein 1S

Hepatitis B Virus Surface Antigen Selectively Inhibits TLR2 Ligand–Induced IL-12 Production in Monocytes/Macrophages by Interfering with JNK Activation